Replies to post #229916 on Amarin Corp Plc (AMRN)

[Atom0aks]

Atom0aks, let me get this straight:
1. You don't believe that only 4 out 16 panel members were opposed to fda granting primary label and you are waiting for the adcom meeting transcript to make your own count.
2. At the same time you have stated that many other adcom members were opposed to fda granting primary label and for this you actually don't need adcom meeting transcript.

Unless you delete your previous posts, everyone on this board can see for themselves, that both of these statements are true.

Kim

I am not quite sure what you are trying to get at, but just to make it clearer for you:

1. I think more than four members were opposed to a primary prevention label.
2. I am not certain how much more because their rationale would go on tangents that included aspects of the primary prevention population such as patient age, which made their decision less clear.
3. Before I am confident about the division of the committee, I am waiting to closely review the final minutes and transcripts.

Does that make sense?